ConductScience.org, home

Paper2172121

Cellular DNA content as a new prognostic tool in patients with borderline tumors of the ovary.

Kaern J and 4 others. Gynecol Oncol, 1990. Cited by 60 papers, by iCite.

Cite this record

ConductScience Library. Cellular DNA content as a new prognostic tool in patients with borderline tumors of the ovary. Papers, record 2172121. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/2172121

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Cellular DNA content as a new prognostic tool in patients with borderline tumors of the ovary.
PubMed
Journal
Gynecol Oncol
PubMed
Year
1990
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
60
iCite
Relative citation ratio, by iCite
2.91
iCite
Revised in PubMed
2019-08-24
PubMed

Authors5

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Kaern JJ
2Trope CC
3Kjorstad KEK E
4Abeler VV
5Pettersen EOE O

Source PubMed

Download CSV of authors

Topics18

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Adenocarcinoma, MucinousMajor topic
CystadenocarcinomaMajor topic
DNA, NeoplasmMajor topic
Ovarian NeoplasmsMajor topic
Adolescent
Adult
Aged
Aged, 80 and over
Female
Flow Cytometry
Humans
Male
Middle Aged
Neoplasm Staging
Ploidies
Prognosis
Retrospective Studies
Survival Analysis

Source PubMed

Download CSV of topics

Cited by8

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 60 citations.

PMIDTitleJournalYearIn PapersSource
29203995Management of Borderline Ovarian Tumors-Still a Gray Zone.Indian J Surg Oncol2017https://conductscience.org/library/papers/29203995PubMed
26568913Pathogenesis of serous, extra-uterine Müllerian epithelial cancer and therapeutic implications.Transl Cancer Res2015https://conductscience.org/library/papers/26568913PubMed
23024155Diagnosis, treatment, and follow-up of borderline ovarian tumors.Oncologist2012https://conductscience.org/library/papers/23024155PubMed
17519898Increased chromosomal stability in cultures of ovarian tumours of low malignant potential compared to cystadenomas.Br J Cancer2007https://conductscience.org/library/papers/17519898PubMed
15026802Allelic loss at 19q12 and Xq11-12 predict an adverse clinical outcome in patients with mucinous ovarian tumours of low malignant potential.Br J Cancer2004https://conductscience.org/library/papers/15026802PubMed
9771445Multivariate analyses of DNA index, p62c-myc, and clinicopathological status of patients with ovarian cancer.J Clin Pathol1998https://conductscience.org/library/papers/9771445PubMed
7947090Regulation of cell proliferation under extreme and moderate hypoxia: the role of pyrimidine (deoxy)nucleotides.Br J Cancer1994https://conductscience.org/library/papers/7947090PubMed
1931622DNA ploidy in primary testicular cancer.Br J Cancer1991https://conductscience.org/library/papers/1931622PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/2172121

GET https://conductscience.org/api/papers/v1/2172121/authors